Nuo Therapeutics AURX
OTC AURX
$1.06 -0.07 (-6.19%)
As of: Nov 19, 2026 · 9:37 AM EST

Nuo Therapeutics (AURX) Cash from Financing Activities (2010 - 2026)

Updated

Nuo Therapeutics' Cash from Financing Activities was $675,000 in Q2 2026, up 35.0% from the prior quarter.

Analysis

Nuo Therapeutics (AURX) Cash from Financing Activities (2010 - 2026) Analysis & Trends

For FY2025, Cash from Financing Activities at Nuo Therapeutics came in at $1.4 million, down 19.3% from FY2024.

  • Cash from Financing Activities has now declined for three consecutive years, though with a five-year compound annual growth rate of 48.4% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $1.74 million in FY2024 (-12.8%), $2 million in FY2023 (-55.2%), $4.46 million in FY2022 (+224.7%) and $1.37 million in FY2021 (+604.1%).
  • Quarterly Cash from Financing Activities has moved between $90,417 (Q4 2024) and $3.96 million (Q2 2022) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in two of the last four quarters, with growth averaging 87.8%.
  • Per Business Quant data, AURX's Cash from Financing Activities in the three quarters before Q2 2026 was $500,000 (Q1 2026), $500,000 (Q4 2025) and $904,959 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn -1.06 Bn
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn -2.41 Bn
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn -262.00 Mn
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn -2.89 Bn
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn -343.00 Mn
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn -1.39 Bn
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn -569.00 Mn
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn -100.80 Mn
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 471.00 Mn
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 675,000.00
Mar 31, 2026 500,000.00
Dec 31, 2025 500,000.00
Sep 30, 2025 904,959.00
Dec 31, 2024 90,417.00
Sep 30, 2024 849,125.00
Jun 30, 2024 802,075.00
Dec 31, 2023 962,500.00
Sep 30, 2023 1.04 Mn
Sep 30, 2022 500,000.00
Jun 30, 2022 3.96 Mn
Dec 31, 2021 1.37 Mn
Dec 31, 2020 195,000.00
Sep 30, 2018 315,800.00
Dec 31, 2017 -77,971.00
Mar 31, 2016 2.32 Mn
Sep 30, 2014 -81,406.00
Jun 30, 2014 22.16 Mn
Mar 31, 2014 8.35 Mn
Dec 31, 2013 2.11 Mn
API Access

Nuo Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AURX&period=max&api_key=YOUR_API_KEY